We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.62%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$7B
AUM Growth
+$1.45B
Cap. Flow
+$669M
Cap. Flow %
9.56%
Top 10 Hldgs %
35.33%
Holding
139
New
45
Increased
38
Reduced
14
Closed
33

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$143M
2
UNH icon
UnitedHealth
UNH
+$135M
3
DT icon
Dynatrace
DT
+$86.6M
4
OPEN icon
Opendoor
OPEN
+$75.7M
5
EXAS
Exact Sciences
EXAS
+$73.9M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$106M
2
APH icon
Amphenol
APH
+$99.8M
3
GAP
The Gap Inc
GAP
+$96.2M
4
AMZN icon
Amazon
AMZN
+$95.6M
5
CPRT icon
Copart
CPRT
+$71M

Sector Composition

Rank Sector Weight
1 Technology 22.5%
2 Healthcare 21.05%
3 Consumer Discretionary 16.78%
4 Industrials 15.25%
5 Communication Services 11.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPENW
76
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$5.2M 0.07%
673,677
– –
SNRHU
77
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
$5.14M 0.07%
+500,000
New +$5.16M
BURU
78
DELISTED
NUBURU INC
BURU
$4.96M 0.07%
+2,392
New +$4.72M
CCCC icon
79
C4 Therapeutics
CCCC
$412M
$4.75M 0.07%
+143,482
New +$4.16M
BLU
80
DELISTED
BELLUS Health Inc.
BLU
$4.71M 0.07%
1,540,900
+1,300,000
+540% +$3.52M
INZY
81
DELISTED
Inozyme Pharma
INZY
$4.42M 0.06%
+214,311
New +$5.11M
OTIC
82
DELISTED
Otonomy, Inc.
OTIC
$4.03M 0.06%
622,700
+372,700
+149% +$1.69M
CLOVW
83
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$3.79M 0.05%
946,499
-1,095,970
-54% -$2.59M
EPIX
84
DELISTED
ESSA Pharma
EPIX
$3.56M 0.05%
298,800
– –
NAUT icon
85
Nautilus Biotechnolgy
NAUT
$115M
$3.25M 0.05%
300,000
– –
MLTX icon
86
MoonLake Immunotherapeutics
MLTX
$1.55B
$2.27M 0.03%
+200,000
New +$2.12M
BLSA
87
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2.23M 0.03%
+200,000
New +$2.14M
TMPM
88
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$2M 0.03%
+200,000
New +$2M
WPF.WS
89
DELISTED
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
$1.96M 0.03%
774,375
-94,424
-11% -$179K
BMY.RT
90
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.94M 0.03%
2,813,900
+1,512,932
+116% +$3.22M
JWS.WS
91
DELISTED
Jaws Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary
JWS.WS
$1.82M 0.03%
674,566
– –
SOFIW
92
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
$1.76M 0.03%
+499,999
New +$1.38M
IPOD.WS
93
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$1.67M 0.02%
+449,999
New +$1.54M
IPOF.WS
94
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$1.64M 0.02%
+499,999
New +$1.35M
ORGNW
95
DELISTED
Origin Materials Inc Warrants
ORGNW
$1.34M 0.02%
607,833
– –
TNGX icon
96
Tango Therapeutics
TNGX
$4.41B
$1.14M 0.02%
100,000
– –
EUCR
97
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1M 0.01%
+99,999
New +$1.01M
FLACU
98
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$908K 0.01%
+87,500
New +$913K
BURU.WS
99
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$700K 0.01%
+500,000
New +$522K
TREB.WS
100
DELISTED
Trebia Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
TREB.WS
$689K 0.01%
331,372
-107,294
-24% -$166K
2 3
4
5 6

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Suvretta Capital Management held 139 positions worth $7B, up 26% from $5.55B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Suvretta Capital Management deployed $669M of net new capital in Q4 2020, opening 45 new positions and adding to 38 existing holdings. Its largest new stake was Dynatrace: 2,179,910 shares worth $94.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Amazon, an estimated $95.6M trimmed.

  • Suvretta Capital Management's largest Q4 2020 buy was Dynatrace: 2,179,910 shares worth $94.3M.
  • Suvretta Capital Management added most to Netflix in Q4 2020, an estimated $143M increase.
  • Suvretta Capital Management's biggest Q4 2020 reduction was Amazon, cutting an estimated $95.6M.
  • Suvretta Capital Management fully exited PayPal in Q4 2020, selling an estimated $106M.
  • Suvretta Capital Management's ten largest holdings make up 35% of its $7B portfolio in Q4 2020.
  • Suvretta Capital Management opened 45 new positions and closed 33 in Q4 2020.
  • Suvretta Capital Management's portfolio value rose 26% quarter-over-quarter to $7B.

Based on Suvretta Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.